v v n Search Results


91
Santa Cruz Biotechnology n myc shrna
The change in the molecular and cellular characteristics of N‐myc–downregulated IMR‐32 cells. A, Expression level of N‐myc and Bcl‐2 family (Bcl‐2, Bid and Bax) in SK‐N‐MC, IMR‐32 and SK‐N‐BE cells determined by immunoblotting. B, Expression level of N‐myc, Bcl‐2, Bid and Bax in IMR‐32 cells after treatment with 750 ng/mL cisplatin and/or 100 ng/mL TRAIL for 24 h. C, Expression level of N‐myc in IMR‐32 cells infected with lentivirus carrying <t>shRNA‐targeting</t> N‐myc. D, Phase‐contrast images of these cells. E, Expression level of N‐myc, Bcl‐2, Bid, Bax, p27 Kip1 and p21 Cip1/Waf1 in N‐myc–downregulated IMR‐32 cells determined by immunoblotting. F, Total number of viable cells determined by trypan blue exclusion method using a hemocytometer. G, Measurement of mitochondrial membrane potential (Ψm) in N‐myc–downregulated IMR‐32 cells by TMRE staining. H, I, Analysis of caspase‐8 expression and caspase‐9, caspase‐3 and PARP cleavage in N‐myc–downregulated IMR‐32 cells by immunoblotting. H, Caspase‐8 expression was undetected in N‐myc–downregulated IMR‐32 cells. SK‐N‐MC cells were used as a positive control. I, Caspase‐3, caspase‐9 and PARP were slightly cleaved in N‐myc–downregulated IMR‐32 cells. β‐Actin was used as an internal control. Representative immunoblots are shown
N Myc Shrna, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/v+v+n/N-Myc+shRNA+(h)+Lentiviral+Particles/pmc06536445-27-77-87
Average 91 stars, based on 1 article reviews
n myc shrna - by Bioz Stars, 2026-11
91/100 stars
  Buy from Supplier

92
Santa Cruz Biotechnology n cadherin shrna lentiviral particles
Fig. 3 | Cell–cell and cell–matrix adhesions are required for fibroblast spreading. a Western blot showing N-cadherin expression level in Control fibroblasts (Ctrl, transfected with scrambled <t>shRNA)</t> and fibroblast depleted from N-cadherin (shN-cadh). GAPDH is used as a loading control. b Frequency of capsules in which fibroblasts envel- oped cancer cells. Capsules contain cancer cells with control or N-cadherin-depleted fibroblasts. t = 0 corresponds to the confluent stage. n ≥30 capsules per condition. c. Western blot showing Fibronectin expression level in Control fibroblasts (shCtrl, transfected with scrambled shRNA) and fibroblast depleted from fibronectin (shFN) using five differ- ent shRNA probes. GAPDH is used as a loading control. d Frequency of capsules in which fibroblasts enveloped cancer cells. Capsules contain fibroblasts showing different degrees of fibronectin depletion. t = 0 corresponds to the confluent stage. n = 40 capsules. e Confocal images of co-culture at day 5, which corresponds to the early stage, before con- fluency (two upper rows) and 10 days, which cor- responds to the final stage with fully spread fibroblasts (two bottom rows). Both cell types are labeled with phalloidin (F-actin, red), fibroblasts express GFP (green), fibronectin is labeled with antibodies (magenta). Scale bar: 100 μm. f Confocal images of co-culture at the onset of fibroblasts spreading. Fibroblasts expressed GFP (green), can- cer cells are unstained, and fibronectin is labeled with antibodies (magenta). Insets, higher magnifi- cation of boxed regions. Scale bars: 20 μm.
N Cadherin Shrna Lentiviral Particles, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/v+v+n/N-cadherin+shRNA+(m)+Lentiviral+Particles/pm38360973-282-51-55
Average 92 stars, based on 1 article reviews
n cadherin shrna lentiviral particles - by Bioz Stars, 2026-11
92/100 stars
  Buy from Supplier

93
Santa Cruz Biotechnology shrna santa cruz sc 108080 v hsc70 shrna santa cruz sc 62655 v hsp70 shrna santa cruz sc 29352 v biological samples spiromics bal nhlbi n a control
Fig. 3 | Cell–cell and cell–matrix adhesions are required for fibroblast spreading. a Western blot showing N-cadherin expression level in Control fibroblasts (Ctrl, transfected with scrambled <t>shRNA)</t> and fibroblast depleted from N-cadherin (shN-cadh). GAPDH is used as a loading control. b Frequency of capsules in which fibroblasts envel- oped cancer cells. Capsules contain cancer cells with control or N-cadherin-depleted fibroblasts. t = 0 corresponds to the confluent stage. n ≥30 capsules per condition. c. Western blot showing Fibronectin expression level in Control fibroblasts (shCtrl, transfected with scrambled shRNA) and fibroblast depleted from fibronectin (shFN) using five differ- ent shRNA probes. GAPDH is used as a loading control. d Frequency of capsules in which fibroblasts enveloped cancer cells. Capsules contain fibroblasts showing different degrees of fibronectin depletion. t = 0 corresponds to the confluent stage. n = 40 capsules. e Confocal images of co-culture at day 5, which corresponds to the early stage, before con- fluency (two upper rows) and 10 days, which cor- responds to the final stage with fully spread fibroblasts (two bottom rows). Both cell types are labeled with phalloidin (F-actin, red), fibroblasts express GFP (green), fibronectin is labeled with antibodies (magenta). Scale bar: 100 μm. f Confocal images of co-culture at the onset of fibroblasts spreading. Fibroblasts expressed GFP (green), can- cer cells are unstained, and fibronectin is labeled with antibodies (magenta). Insets, higher magnifi- cation of boxed regions. Scale bars: 20 μm.
Shrna Santa Cruz Sc 108080 V Hsc70 Shrna Santa Cruz Sc 62655 V Hsp70 Shrna Santa Cruz Sc 29352 V Biological Samples Spiromics Bal Nhlbi N A Control, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/v+v+n/N-SMase2+shRNA+(h)+Lentiviral+Particles/pm40553562-364-92-93
Average 93 stars, based on 1 article reviews
shrna santa cruz sc 108080 v hsc70 shrna santa cruz sc 62655 v hsp70 shrna santa cruz sc 29352 v biological samples spiromics bal nhlbi n a control - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

93
Santa Cruz Biotechnology sc 29403 v n cadherin shrna lentiviral particles
Fig. 3 | Cell–cell and cell–matrix adhesions are required for fibroblast spreading. a Western blot showing N-cadherin expression level in Control fibroblasts (Ctrl, transfected with scrambled <t>shRNA)</t> and fibroblast depleted from N-cadherin (shN-cadh). GAPDH is used as a loading control. b Frequency of capsules in which fibroblasts envel- oped cancer cells. Capsules contain cancer cells with control or N-cadherin-depleted fibroblasts. t = 0 corresponds to the confluent stage. n ≥30 capsules per condition. c. Western blot showing Fibronectin expression level in Control fibroblasts (shCtrl, transfected with scrambled shRNA) and fibroblast depleted from fibronectin (shFN) using five differ- ent shRNA probes. GAPDH is used as a loading control. d Frequency of capsules in which fibroblasts enveloped cancer cells. Capsules contain fibroblasts showing different degrees of fibronectin depletion. t = 0 corresponds to the confluent stage. n = 40 capsules. e Confocal images of co-culture at day 5, which corresponds to the early stage, before con- fluency (two upper rows) and 10 days, which cor- responds to the final stage with fully spread fibroblasts (two bottom rows). Both cell types are labeled with phalloidin (F-actin, red), fibroblasts express GFP (green), fibronectin is labeled with antibodies (magenta). Scale bar: 100 μm. f Confocal images of co-culture at the onset of fibroblasts spreading. Fibroblasts expressed GFP (green), can- cer cells are unstained, and fibronectin is labeled with antibodies (magenta). Insets, higher magnifi- cation of boxed regions. Scale bars: 20 μm.
Sc 29403 V N Cadherin Shrna Lentiviral Particles, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/v+v+n/N-cadherin+shRNA+(h)+Lentiviral+Particles/pmc09418860-481-4-9
Average 93 stars, based on 1 article reviews
sc 29403 v n cadherin shrna lentiviral particles - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

90
Santa Cruz Biotechnology anti nras
A Serial circulating and lung‐homed tumor cells at 4 weeks after s.c. injection of 10 6 <t>p</t> <t>eGFP</t> ‐expressing tumor cells ( n = 4/group). Histogram: flow cytometry of tumor cells. Images: representative lung photographs and biofluorescence at 445‐ to 490‐nm excitation and 515‐ to 575‐nm emission. B, C <t>NRAS</t> mRNA and protein of MC38 and HEK293T cells expressing control (p C ), wild‐type NRAS (p NRAS WT ), and NRAS Q61K (p NRAS Q61K ) plasmids by qPCR ( n = 3; shown are NRAS relative to Gusb or GUSB levels) and immunoblotting (shown is one representative of three experiments). D NRAS and β‐actin immunoblots, incidence table, and multiplicity (graph) of lung metastases of C57BL/6 mice at 4 weeks after s.c. delivery of 10 6 MC38 cells expressing p C , p NRAS WT , and p NRAS Q61K plasmids ( n is given in table; arrows indicate the clones used for experiments). E Lung fraction occupied by metastases (graphs), and exemplary images of proliferating cell nuclear antigen (PCNA)‐stained lung sections of NOD/SCID mice at 11 weeks after s.c. ( n = 7–8/group) and i.v. ( n = 5/group) delivery of 3 × 10 6 HEK293T cells expressing p C and p NRAS Q61K . Data information: Cell lines are described in the text. Arrows: micrometastases (red) and macrometastases (black). All data are presented as mean ± SEM. P : probability by two‐way ANOVA (A, dot plot), one‐way ANOVA (A, C, D, bar graphs), Fisher's exact test (D, table), or Student's t ‐test (E). *, **, and ***: P < 0.05, P < 0.01, and P < 0.001, respectively, for indicated comparisons (or for comparison with p C in C and D) by Bonferroni post‐test. Source data are available online for this figure.
Anti Nras, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/v+v+n/N-Ras+shRNA+(m)+Lentiviral+Particles/pmc05697015-146-9-25
Average 90 stars, based on 1 article reviews
anti nras - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

96
Chem Impex International tetramethylfluoroformamidiniun hexafluorophosphate
A Serial circulating and lung‐homed tumor cells at 4 weeks after s.c. injection of 10 6 <t>p</t> <t>eGFP</t> ‐expressing tumor cells ( n = 4/group). Histogram: flow cytometry of tumor cells. Images: representative lung photographs and biofluorescence at 445‐ to 490‐nm excitation and 515‐ to 575‐nm emission. B, C <t>NRAS</t> mRNA and protein of MC38 and HEK293T cells expressing control (p C ), wild‐type NRAS (p NRAS WT ), and NRAS Q61K (p NRAS Q61K ) plasmids by qPCR ( n = 3; shown are NRAS relative to Gusb or GUSB levels) and immunoblotting (shown is one representative of three experiments). D NRAS and β‐actin immunoblots, incidence table, and multiplicity (graph) of lung metastases of C57BL/6 mice at 4 weeks after s.c. delivery of 10 6 MC38 cells expressing p C , p NRAS WT , and p NRAS Q61K plasmids ( n is given in table; arrows indicate the clones used for experiments). E Lung fraction occupied by metastases (graphs), and exemplary images of proliferating cell nuclear antigen (PCNA)‐stained lung sections of NOD/SCID mice at 11 weeks after s.c. ( n = 7–8/group) and i.v. ( n = 5/group) delivery of 3 × 10 6 HEK293T cells expressing p C and p NRAS Q61K . Data information: Cell lines are described in the text. Arrows: micrometastases (red) and macrometastases (black). All data are presented as mean ± SEM. P : probability by two‐way ANOVA (A, dot plot), one‐way ANOVA (A, C, D, bar graphs), Fisher's exact test (D, table), or Student's t ‐test (E). *, **, and ***: P < 0.05, P < 0.01, and P < 0.001, respectively, for indicated comparisons (or for comparison with p C in C and D) by Bonferroni post‐test. Source data are available online for this figure.
Tetramethylfluoroformamidiniun Hexafluorophosphate, supplied by Chem Impex International, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/v+v+n/Tetramethylfluoroformamidiniun+hexafluorophosphate/pmc06212315__NIHMS1504512___supplement___1-28-0-3
Average 96 stars, based on 1 article reviews
tetramethylfluoroformamidiniun hexafluorophosphate - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

95
Chem Impex International benotriazole 1 yl oxy pyrrolidino phosphonium hexafluorophosphate pybop
A Serial circulating and lung‐homed tumor cells at 4 weeks after s.c. injection of 10 6 <t>p</t> <t>eGFP</t> ‐expressing tumor cells ( n = 4/group). Histogram: flow cytometry of tumor cells. Images: representative lung photographs and biofluorescence at 445‐ to 490‐nm excitation and 515‐ to 575‐nm emission. B, C <t>NRAS</t> mRNA and protein of MC38 and HEK293T cells expressing control (p C ), wild‐type NRAS (p NRAS WT ), and NRAS Q61K (p NRAS Q61K ) plasmids by qPCR ( n = 3; shown are NRAS relative to Gusb or GUSB levels) and immunoblotting (shown is one representative of three experiments). D NRAS and β‐actin immunoblots, incidence table, and multiplicity (graph) of lung metastases of C57BL/6 mice at 4 weeks after s.c. delivery of 10 6 MC38 cells expressing p C , p NRAS WT , and p NRAS Q61K plasmids ( n is given in table; arrows indicate the clones used for experiments). E Lung fraction occupied by metastases (graphs), and exemplary images of proliferating cell nuclear antigen (PCNA)‐stained lung sections of NOD/SCID mice at 11 weeks after s.c. ( n = 7–8/group) and i.v. ( n = 5/group) delivery of 3 × 10 6 HEK293T cells expressing p C and p NRAS Q61K . Data information: Cell lines are described in the text. Arrows: micrometastases (red) and macrometastases (black). All data are presented as mean ± SEM. P : probability by two‐way ANOVA (A, dot plot), one‐way ANOVA (A, C, D, bar graphs), Fisher's exact test (D, table), or Student's t ‐test (E). *, **, and ***: P < 0.05, P < 0.01, and P < 0.001, respectively, for indicated comparisons (or for comparison with p C in C and D) by Bonferroni post‐test. Source data are available online for this figure.
Benotriazole 1 Yl Oxy Pyrrolidino Phosphonium Hexafluorophosphate Pybop, supplied by Chem Impex International, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/v+v+n/N%2CN%2CN%E2%80%99%2CN%E2%80%99Bis(tetramethylene)-O-(N-succinimidyl)uronium+hexafluorophosphate/pm26317395__ja5b05896_si_001-2-4-14
Average 95 stars, based on 1 article reviews
benotriazole 1 yl oxy pyrrolidino phosphonium hexafluorophosphate pybop - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

90
honeywell international load cells honeywell, ltd., range ± 498.1 n, voltage ± 5 v, high-sensitivity transducer 0.045 v/n
A Serial circulating and lung‐homed tumor cells at 4 weeks after s.c. injection of 10 6 <t>p</t> <t>eGFP</t> ‐expressing tumor cells ( n = 4/group). Histogram: flow cytometry of tumor cells. Images: representative lung photographs and biofluorescence at 445‐ to 490‐nm excitation and 515‐ to 575‐nm emission. B, C <t>NRAS</t> mRNA and protein of MC38 and HEK293T cells expressing control (p C ), wild‐type NRAS (p NRAS WT ), and NRAS Q61K (p NRAS Q61K ) plasmids by qPCR ( n = 3; shown are NRAS relative to Gusb or GUSB levels) and immunoblotting (shown is one representative of three experiments). D NRAS and β‐actin immunoblots, incidence table, and multiplicity (graph) of lung metastases of C57BL/6 mice at 4 weeks after s.c. delivery of 10 6 MC38 cells expressing p C , p NRAS WT , and p NRAS Q61K plasmids ( n is given in table; arrows indicate the clones used for experiments). E Lung fraction occupied by metastases (graphs), and exemplary images of proliferating cell nuclear antigen (PCNA)‐stained lung sections of NOD/SCID mice at 11 weeks after s.c. ( n = 7–8/group) and i.v. ( n = 5/group) delivery of 3 × 10 6 HEK293T cells expressing p C and p NRAS Q61K . Data information: Cell lines are described in the text. Arrows: micrometastases (red) and macrometastases (black). All data are presented as mean ± SEM. P : probability by two‐way ANOVA (A, dot plot), one‐way ANOVA (A, C, D, bar graphs), Fisher's exact test (D, table), or Student's t ‐test (E). *, **, and ***: P < 0.05, P < 0.01, and P < 0.001, respectively, for indicated comparisons (or for comparison with p C in C and D) by Bonferroni post‐test. Source data are available online for this figure.
Load Cells Honeywell, Ltd., Range ± 498.1 N, Voltage ± 5 V, High Sensitivity Transducer 0.045 V/N, supplied by honeywell international, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/v+v+n/load+cells+honeywell++ltd+++range+++498+1+n++voltage+++5+v++high+sensitivity+transducer+0+045+v+n/pmc06059088-63-16-18
Average 90 stars, based on 1 article reviews
load cells honeywell, ltd., range ± 498.1 n, voltage ± 5 v, high-sensitivity transducer 0.045 v/n - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Strem Chemicals titanium tetrabutoxide (c16h36o4ti) [titanium ( v)-n-butoxide
A Serial circulating and lung‐homed tumor cells at 4 weeks after s.c. injection of 10 6 <t>p</t> <t>eGFP</t> ‐expressing tumor cells ( n = 4/group). Histogram: flow cytometry of tumor cells. Images: representative lung photographs and biofluorescence at 445‐ to 490‐nm excitation and 515‐ to 575‐nm emission. B, C <t>NRAS</t> mRNA and protein of MC38 and HEK293T cells expressing control (p C ), wild‐type NRAS (p NRAS WT ), and NRAS Q61K (p NRAS Q61K ) plasmids by qPCR ( n = 3; shown are NRAS relative to Gusb or GUSB levels) and immunoblotting (shown is one representative of three experiments). D NRAS and β‐actin immunoblots, incidence table, and multiplicity (graph) of lung metastases of C57BL/6 mice at 4 weeks after s.c. delivery of 10 6 MC38 cells expressing p C , p NRAS WT , and p NRAS Q61K plasmids ( n is given in table; arrows indicate the clones used for experiments). E Lung fraction occupied by metastases (graphs), and exemplary images of proliferating cell nuclear antigen (PCNA)‐stained lung sections of NOD/SCID mice at 11 weeks after s.c. ( n = 7–8/group) and i.v. ( n = 5/group) delivery of 3 × 10 6 HEK293T cells expressing p C and p NRAS Q61K . Data information: Cell lines are described in the text. Arrows: micrometastases (red) and macrometastases (black). All data are presented as mean ± SEM. P : probability by two‐way ANOVA (A, dot plot), one‐way ANOVA (A, C, D, bar graphs), Fisher's exact test (D, table), or Student's t ‐test (E). *, **, and ***: P < 0.05, P < 0.01, and P < 0.001, respectively, for indicated comparisons (or for comparison with p C in C and D) by Bonferroni post‐test. Source data are available online for this figure.
Titanium Tetrabutoxide (C16h36o4ti) [Titanium ( V) N Butoxide, supplied by Strem Chemicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/v+v+n/titanium+tetrabutoxide++c16h36o4ti+++titanium+++v++n+butoxide/ppr0404553-48-28-34
Average 90 stars, based on 1 article reviews
titanium tetrabutoxide (c16h36o4ti) [titanium ( v)-n-butoxide - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Fairchild Semiconductor International Inc 400 v n-channel mosfet q1 fqp6n40c
A Serial circulating and lung‐homed tumor cells at 4 weeks after s.c. injection of 10 6 <t>p</t> <t>eGFP</t> ‐expressing tumor cells ( n = 4/group). Histogram: flow cytometry of tumor cells. Images: representative lung photographs and biofluorescence at 445‐ to 490‐nm excitation and 515‐ to 575‐nm emission. B, C <t>NRAS</t> mRNA and protein of MC38 and HEK293T cells expressing control (p C ), wild‐type NRAS (p NRAS WT ), and NRAS Q61K (p NRAS Q61K ) plasmids by qPCR ( n = 3; shown are NRAS relative to Gusb or GUSB levels) and immunoblotting (shown is one representative of three experiments). D NRAS and β‐actin immunoblots, incidence table, and multiplicity (graph) of lung metastases of C57BL/6 mice at 4 weeks after s.c. delivery of 10 6 MC38 cells expressing p C , p NRAS WT , and p NRAS Q61K plasmids ( n is given in table; arrows indicate the clones used for experiments). E Lung fraction occupied by metastases (graphs), and exemplary images of proliferating cell nuclear antigen (PCNA)‐stained lung sections of NOD/SCID mice at 11 weeks after s.c. ( n = 7–8/group) and i.v. ( n = 5/group) delivery of 3 × 10 6 HEK293T cells expressing p C and p NRAS Q61K . Data information: Cell lines are described in the text. Arrows: micrometastases (red) and macrometastases (black). All data are presented as mean ± SEM. P : probability by two‐way ANOVA (A, dot plot), one‐way ANOVA (A, C, D, bar graphs), Fisher's exact test (D, table), or Student's t ‐test (E). *, **, and ***: P < 0.05, P < 0.01, and P < 0.001, respectively, for indicated comparisons (or for comparison with p C in C and D) by Bonferroni post‐test. Source data are available online for this figure.
400 V N Channel Mosfet Q1 Fqp6n40c, supplied by Fairchild Semiconductor International Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/v+v+n/400+v+n+channel+mosfet+q1+fqp6n40c/us08749159-195-15-23
Average 90 stars, based on 1 article reviews
400 v n-channel mosfet q1 fqp6n40c - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Verlag GmbH low carbon q690 v-n and v-n-cr microalloyed high-strength steels
A Serial circulating and lung‐homed tumor cells at 4 weeks after s.c. injection of 10 6 <t>p</t> <t>eGFP</t> ‐expressing tumor cells ( n = 4/group). Histogram: flow cytometry of tumor cells. Images: representative lung photographs and biofluorescence at 445‐ to 490‐nm excitation and 515‐ to 575‐nm emission. B, C <t>NRAS</t> mRNA and protein of MC38 and HEK293T cells expressing control (p C ), wild‐type NRAS (p NRAS WT ), and NRAS Q61K (p NRAS Q61K ) plasmids by qPCR ( n = 3; shown are NRAS relative to Gusb or GUSB levels) and immunoblotting (shown is one representative of three experiments). D NRAS and β‐actin immunoblots, incidence table, and multiplicity (graph) of lung metastases of C57BL/6 mice at 4 weeks after s.c. delivery of 10 6 MC38 cells expressing p C , p NRAS WT , and p NRAS Q61K plasmids ( n is given in table; arrows indicate the clones used for experiments). E Lung fraction occupied by metastases (graphs), and exemplary images of proliferating cell nuclear antigen (PCNA)‐stained lung sections of NOD/SCID mice at 11 weeks after s.c. ( n = 7–8/group) and i.v. ( n = 5/group) delivery of 3 × 10 6 HEK293T cells expressing p C and p NRAS Q61K . Data information: Cell lines are described in the text. Arrows: micrometastases (red) and macrometastases (black). All data are presented as mean ± SEM. P : probability by two‐way ANOVA (A, dot plot), one‐way ANOVA (A, C, D, bar graphs), Fisher's exact test (D, table), or Student's t ‐test (E). *, **, and ***: P < 0.05, P < 0.01, and P < 0.001, respectively, for indicated comparisons (or for comparison with p C in C and D) by Bonferroni post‐test. Source data are available online for this figure.
Low Carbon Q690 V N And V N Cr Microalloyed High Strength Steels, supplied by Verlag GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/v+v+n/low+carbon+q690+v+n+and+v+n+cr+microalloyed+high+strength+steels/10__1002_slash_srin__201970083-52-18-31
Average 90 stars, based on 1 article reviews
low carbon q690 v-n and v-n-cr microalloyed high-strength steels - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Anatrace 0.02% (v/v) n -undecyl-β- d -maltopyranoside
A Serial circulating and lung‐homed tumor cells at 4 weeks after s.c. injection of 10 6 <t>p</t> <t>eGFP</t> ‐expressing tumor cells ( n = 4/group). Histogram: flow cytometry of tumor cells. Images: representative lung photographs and biofluorescence at 445‐ to 490‐nm excitation and 515‐ to 575‐nm emission. B, C <t>NRAS</t> mRNA and protein of MC38 and HEK293T cells expressing control (p C ), wild‐type NRAS (p NRAS WT ), and NRAS Q61K (p NRAS Q61K ) plasmids by qPCR ( n = 3; shown are NRAS relative to Gusb or GUSB levels) and immunoblotting (shown is one representative of three experiments). D NRAS and β‐actin immunoblots, incidence table, and multiplicity (graph) of lung metastases of C57BL/6 mice at 4 weeks after s.c. delivery of 10 6 MC38 cells expressing p C , p NRAS WT , and p NRAS Q61K plasmids ( n is given in table; arrows indicate the clones used for experiments). E Lung fraction occupied by metastases (graphs), and exemplary images of proliferating cell nuclear antigen (PCNA)‐stained lung sections of NOD/SCID mice at 11 weeks after s.c. ( n = 7–8/group) and i.v. ( n = 5/group) delivery of 3 × 10 6 HEK293T cells expressing p C and p NRAS Q61K . Data information: Cell lines are described in the text. Arrows: micrometastases (red) and macrometastases (black). All data are presented as mean ± SEM. P : probability by two‐way ANOVA (A, dot plot), one‐way ANOVA (A, C, D, bar graphs), Fisher's exact test (D, table), or Student's t ‐test (E). *, **, and ***: P < 0.05, P < 0.01, and P < 0.001, respectively, for indicated comparisons (or for comparison with p C in C and D) by Bonferroni post‐test. Source data are available online for this figure.
0.02% (V/V) N Undecyl β D Maltopyranoside, supplied by Anatrace, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/v+v+n/0+02+++v+v++n++undecyl+%CE%B2++d++maltopyranoside/pmc04432310-65-18-62
Average 90 stars, based on 1 article reviews
0.02% (v/v) n -undecyl-β- d -maltopyranoside - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

Image Search Results


The change in the molecular and cellular characteristics of N‐myc–downregulated IMR‐32 cells. A, Expression level of N‐myc and Bcl‐2 family (Bcl‐2, Bid and Bax) in SK‐N‐MC, IMR‐32 and SK‐N‐BE cells determined by immunoblotting. B, Expression level of N‐myc, Bcl‐2, Bid and Bax in IMR‐32 cells after treatment with 750 ng/mL cisplatin and/or 100 ng/mL TRAIL for 24 h. C, Expression level of N‐myc in IMR‐32 cells infected with lentivirus carrying shRNA‐targeting N‐myc. D, Phase‐contrast images of these cells. E, Expression level of N‐myc, Bcl‐2, Bid, Bax, p27 Kip1 and p21 Cip1/Waf1 in N‐myc–downregulated IMR‐32 cells determined by immunoblotting. F, Total number of viable cells determined by trypan blue exclusion method using a hemocytometer. G, Measurement of mitochondrial membrane potential (Ψm) in N‐myc–downregulated IMR‐32 cells by TMRE staining. H, I, Analysis of caspase‐8 expression and caspase‐9, caspase‐3 and PARP cleavage in N‐myc–downregulated IMR‐32 cells by immunoblotting. H, Caspase‐8 expression was undetected in N‐myc–downregulated IMR‐32 cells. SK‐N‐MC cells were used as a positive control. I, Caspase‐3, caspase‐9 and PARP were slightly cleaved in N‐myc–downregulated IMR‐32 cells. β‐Actin was used as an internal control. Representative immunoblots are shown

Journal: Cell Proliferation

Article Title: Inhibition of N‐myc expression sensitizes human neuroblastoma IMR‐32 cells expressing caspase‐8 to TRAIL

doi: 10.1111/cpr.12577

Figure Lengend Snippet: The change in the molecular and cellular characteristics of N‐myc–downregulated IMR‐32 cells. A, Expression level of N‐myc and Bcl‐2 family (Bcl‐2, Bid and Bax) in SK‐N‐MC, IMR‐32 and SK‐N‐BE cells determined by immunoblotting. B, Expression level of N‐myc, Bcl‐2, Bid and Bax in IMR‐32 cells after treatment with 750 ng/mL cisplatin and/or 100 ng/mL TRAIL for 24 h. C, Expression level of N‐myc in IMR‐32 cells infected with lentivirus carrying shRNA‐targeting N‐myc. D, Phase‐contrast images of these cells. E, Expression level of N‐myc, Bcl‐2, Bid, Bax, p27 Kip1 and p21 Cip1/Waf1 in N‐myc–downregulated IMR‐32 cells determined by immunoblotting. F, Total number of viable cells determined by trypan blue exclusion method using a hemocytometer. G, Measurement of mitochondrial membrane potential (Ψm) in N‐myc–downregulated IMR‐32 cells by TMRE staining. H, I, Analysis of caspase‐8 expression and caspase‐9, caspase‐3 and PARP cleavage in N‐myc–downregulated IMR‐32 cells by immunoblotting. H, Caspase‐8 expression was undetected in N‐myc–downregulated IMR‐32 cells. SK‐N‐MC cells were used as a positive control. I, Caspase‐3, caspase‐9 and PARP were slightly cleaved in N‐myc–downregulated IMR‐32 cells. β‐Actin was used as an internal control. Representative immunoblots are shown

Article Snippet: Human recombinant TRAIL, Alamar Blue ® and trypan blue were purchased from Life Technologies (Rockville, MD); interferon (IFN)‐γ, human recombinant DR5/Fc chimera (DR5:Fc) protein and phycoerythrin (PE)‐conjugated antibodies for DR4, DR5, DcR1 and DcR2, from R&D Systems (Minneapolis, MN); antibodies for N‐myc, Bid, p27 Kip1 , p21 Cip1/Waf1 , caspase‐3 and caspase‐9, from Cell Signaling Technology (Danvers, MA); and antibodies for caspase‐8, Bcl‐2, Bax, poly(ADP‐ribose) polymerase (PARP) and β‐actin, scrambled shRNA (Cat. No: sc‐108080) as well as N‐myc shRNA (Cat. No: sc‐36003‐V) lentiviral particles, and polybrene, from Santa Cruz Biotechnology (Santa Cruz, CA).

Techniques: Expressing, Western Blot, Infection, shRNA, Membrane, Staining, Positive Control, Control

Fig. 3 | Cell–cell and cell–matrix adhesions are required for fibroblast spreading. a Western blot showing N-cadherin expression level in Control fibroblasts (Ctrl, transfected with scrambled shRNA) and fibroblast depleted from N-cadherin (shN-cadh). GAPDH is used as a loading control. b Frequency of capsules in which fibroblasts envel- oped cancer cells. Capsules contain cancer cells with control or N-cadherin-depleted fibroblasts. t = 0 corresponds to the confluent stage. n ≥30 capsules per condition. c. Western blot showing Fibronectin expression level in Control fibroblasts (shCtrl, transfected with scrambled shRNA) and fibroblast depleted from fibronectin (shFN) using five differ- ent shRNA probes. GAPDH is used as a loading control. d Frequency of capsules in which fibroblasts enveloped cancer cells. Capsules contain fibroblasts showing different degrees of fibronectin depletion. t = 0 corresponds to the confluent stage. n = 40 capsules. e Confocal images of co-culture at day 5, which corresponds to the early stage, before con- fluency (two upper rows) and 10 days, which cor- responds to the final stage with fully spread fibroblasts (two bottom rows). Both cell types are labeled with phalloidin (F-actin, red), fibroblasts express GFP (green), fibronectin is labeled with antibodies (magenta). Scale bar: 100 μm. f Confocal images of co-culture at the onset of fibroblasts spreading. Fibroblasts expressed GFP (green), can- cer cells are unstained, and fibronectin is labeled with antibodies (magenta). Insets, higher magnifi- cation of boxed regions. Scale bars: 20 μm.

Journal: Communications biology

Article Title: Compressive stress triggers fibroblasts spreading over cancer cells to generate carcinoma in situ organization.

doi: 10.1038/s42003-024-05883-6

Figure Lengend Snippet: Fig. 3 | Cell–cell and cell–matrix adhesions are required for fibroblast spreading. a Western blot showing N-cadherin expression level in Control fibroblasts (Ctrl, transfected with scrambled shRNA) and fibroblast depleted from N-cadherin (shN-cadh). GAPDH is used as a loading control. b Frequency of capsules in which fibroblasts envel- oped cancer cells. Capsules contain cancer cells with control or N-cadherin-depleted fibroblasts. t = 0 corresponds to the confluent stage. n ≥30 capsules per condition. c. Western blot showing Fibronectin expression level in Control fibroblasts (shCtrl, transfected with scrambled shRNA) and fibroblast depleted from fibronectin (shFN) using five differ- ent shRNA probes. GAPDH is used as a loading control. d Frequency of capsules in which fibroblasts enveloped cancer cells. Capsules contain fibroblasts showing different degrees of fibronectin depletion. t = 0 corresponds to the confluent stage. n = 40 capsules. e Confocal images of co-culture at day 5, which corresponds to the early stage, before con- fluency (two upper rows) and 10 days, which cor- responds to the final stage with fully spread fibroblasts (two bottom rows). Both cell types are labeled with phalloidin (F-actin, red), fibroblasts express GFP (green), fibronectin is labeled with antibodies (magenta). Scale bar: 100 μm. f Confocal images of co-culture at the onset of fibroblasts spreading. Fibroblasts expressed GFP (green), can- cer cells are unstained, and fibronectin is labeled with antibodies (magenta). Insets, higher magnifi- cation of boxed regions. Scale bars: 20 μm.

Article Snippet: To inhibit cell contractility, spheroids were incubated in a culture medium using 50 μM myosin II inhibitor, blebbistatin (MERCK), or 100 μM ROCK inhibitor, Y-27632 (MERCK). siRNA and shRNA knockdowns HT29 cells and NIH3T3 were infected with MyH9 shRNA lentiviral particles (aYAP, Gift), control shRNA Lentiviral Particles (Santa Cruz Biotechnology, sc-108080), N-cadherin shRNA lentiviral particles (Santa Cruz Biotechnology sc-35999-V) and Fibronectin shRNA lentiviral particles (SHCLNG,MERCK) and shCtrl (SHC002, MERCK).

Techniques: Western Blot, Expressing, Control, Transfection, shRNA, Capsules, Co-Culture Assay, Labeling

A Serial circulating and lung‐homed tumor cells at 4 weeks after s.c. injection of 10 6 p eGFP ‐expressing tumor cells ( n = 4/group). Histogram: flow cytometry of tumor cells. Images: representative lung photographs and biofluorescence at 445‐ to 490‐nm excitation and 515‐ to 575‐nm emission. B, C NRAS mRNA and protein of MC38 and HEK293T cells expressing control (p C ), wild‐type NRAS (p NRAS WT ), and NRAS Q61K (p NRAS Q61K ) plasmids by qPCR ( n = 3; shown are NRAS relative to Gusb or GUSB levels) and immunoblotting (shown is one representative of three experiments). D NRAS and β‐actin immunoblots, incidence table, and multiplicity (graph) of lung metastases of C57BL/6 mice at 4 weeks after s.c. delivery of 10 6 MC38 cells expressing p C , p NRAS WT , and p NRAS Q61K plasmids ( n is given in table; arrows indicate the clones used for experiments). E Lung fraction occupied by metastases (graphs), and exemplary images of proliferating cell nuclear antigen (PCNA)‐stained lung sections of NOD/SCID mice at 11 weeks after s.c. ( n = 7–8/group) and i.v. ( n = 5/group) delivery of 3 × 10 6 HEK293T cells expressing p C and p NRAS Q61K . Data information: Cell lines are described in the text. Arrows: micrometastases (red) and macrometastases (black). All data are presented as mean ± SEM. P : probability by two‐way ANOVA (A, dot plot), one‐way ANOVA (A, C, D, bar graphs), Fisher's exact test (D, table), or Student's t ‐test (E). *, **, and ***: P < 0.05, P < 0.01, and P < 0.001, respectively, for indicated comparisons (or for comparison with p C in C and D) by Bonferroni post‐test. Source data are available online for this figure.

Journal: EMBO Molecular Medicine

Article Title: NRAS destines tumor cells to the lungs

doi: 10.15252/emmm.201606978

Figure Lengend Snippet: A Serial circulating and lung‐homed tumor cells at 4 weeks after s.c. injection of 10 6 p eGFP ‐expressing tumor cells ( n = 4/group). Histogram: flow cytometry of tumor cells. Images: representative lung photographs and biofluorescence at 445‐ to 490‐nm excitation and 515‐ to 575‐nm emission. B, C NRAS mRNA and protein of MC38 and HEK293T cells expressing control (p C ), wild‐type NRAS (p NRAS WT ), and NRAS Q61K (p NRAS Q61K ) plasmids by qPCR ( n = 3; shown are NRAS relative to Gusb or GUSB levels) and immunoblotting (shown is one representative of three experiments). D NRAS and β‐actin immunoblots, incidence table, and multiplicity (graph) of lung metastases of C57BL/6 mice at 4 weeks after s.c. delivery of 10 6 MC38 cells expressing p C , p NRAS WT , and p NRAS Q61K plasmids ( n is given in table; arrows indicate the clones used for experiments). E Lung fraction occupied by metastases (graphs), and exemplary images of proliferating cell nuclear antigen (PCNA)‐stained lung sections of NOD/SCID mice at 11 weeks after s.c. ( n = 7–8/group) and i.v. ( n = 5/group) delivery of 3 × 10 6 HEK293T cells expressing p C and p NRAS Q61K . Data information: Cell lines are described in the text. Arrows: micrometastases (red) and macrometastases (black). All data are presented as mean ± SEM. P : probability by two‐way ANOVA (A, dot plot), one‐way ANOVA (A, C, D, bar graphs), Fisher's exact test (D, table), or Student's t ‐test (E). *, **, and ***: P < 0.05, P < 0.01, and P < 0.001, respectively, for indicated comparisons (or for comparison with p C in C and D) by Bonferroni post‐test. Source data are available online for this figure.

Article Snippet: Lentiviral pools of p eGFP (sc‐108084), random (shC, sc‐108080), anti‐ Nras (sh Nras , sc‐36005‐V), and anti‐ Kras (sh Kras , sc‐43876‐V) shRNAs were from Santa Cruz Biotechnology (Santa Cruz, CA).

Techniques: Injection, Expressing, Flow Cytometry, Control, Western Blot, Clone Assay, Staining, Comparison